Recent News
September–December 2025 headlines highlighted product and partner expansion rather than financial details: Pure announced expanded integrations and partner ecosystem work, including new security and data-protection integrations and broader cloud availability for its Enterprise Data Cloud; company events and analyst meetings tied to Pure//Accelerate in New York also appeared on its calendar.
Technical Analysis
ADX at 29.65 indicates a strong underlying trend, signaling that directional forces contain conviction and likely sustain near-term directional moves.
DI+ peak & reversal and DI- dip & reversal together denote bearish directional pressure; DI+ decreasing while DI- increases points to sellers outweighing buyers and aligns with short-term downside bias against longer-term support levels.
MACD trend peak & reversal with MACD at -3.85 and signal at -2.34 confirms bearish momentum; MACD sits below its signal line, reinforcing the view that momentum currently favors downward price movement.
MRO at -6.92 signals the price sits below the model target, which creates latent upside potential as mean-reversion forces can act if momentum shifts; the MRO trend shows a peak & reversal.
RSI at 50.03 with a peak & reversal label indicates the oscillator lost upward momentum and moved back toward neutral, consistent with fading short-term buying pressure rather than oversold conditions.
Price behavior versus averages frames the setup: last close $70.15 trades below the 20-day average $79.54 and the 50-day average $87.90, while remaining above the 200-day average $64.63—this alignment implies short-term weakness within a longer-term support band. The 12-day EMA at $77.69 shows a peak & reversal. Bollinger context places the close just under the 1x lower band ($70.31), suggesting proximity to intraday support. Volume at 3,859,066 falls below the 10-day average 7,127,764, indicating muted participation on recent moves. Elevated betas (42‑day 2.02; 52‑week 1.89) imply above-market volatility should momentum change.
Fundamental Analysis
EPS matched expectations at $0.58 with an EPS surprise of -0.72%, effectively in line with consensus. Reported earnings growth stands at 34.88% year-over prior period and 155.82% year-over-year in the provided earnings-growth metric, while quarterly earnings momentum shows a QoQ decline of -27.74%.
Revenue metrics present a mixed signal: the current revenue growth value reads 0.0% while QoQ and YoY revenue growth figures show -100% in the provided data; these figures require careful attention when reconciling with operational updates and public communications. Cash-flow margin and cash-flow-to-earnings report as 0.0% in the supplied metrics. Invested capital appears as negative $1,314,177,000 in the dataset, which affects certain capital-efficiency calculations.
Valuation multiples appear elevated: trailing PE equals 145.01 with a QoQ change of +11.01% and YoY change of +37.45%; forward PE registers 175.90 (forward PE QoQ +48.20%). PEG ratios run above 4.0 (PEG 4.16; forward PEG 5.04), implying current multiples price in substantial future growth. Cost of debt registers 0.396%, reflecting low borrowing costs in the capital structure data provided.
Price targets and WMDST valuation: the consensus price-target mean sits at $84.74 (high $159.91; low $39.48). The current valuation as determined by WMDST places the stock at a $84.74 mean target, which sits meaningfully above the last close and supports the MRO signal that the price currently trades below model target.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-10-31 |
| REPORT DATE: | 2025-12-02 |
| NEXT REPORT DATE: | 2026-03-03 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.58 | |
| EPS Actual | $ 0.58 | |
| EPS Difference | $ 0.00 | |
| EPS Surprise | -0.72 % | |
| Forward EPS | $ 0.46 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 145.013 | |
| Price To Earnings QoQ | 11.009 % | |
| Price To Earnings YoY | 37.445 % | |
| Price To Earnings IPRWA | — | |
| PE/G Ratio | 4.157 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 175.903 | |
| Forward PE/G | 5.043 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -1.31 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.396 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | — | |
| Earnings Growth | 34.884 % | |
| Earnings Growth QoQ | -27.74 % | |
| Earnings Growth YoY | 155.823 % | |
| Earnings Growth IPRWA | — | |
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |